1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, doxorubicin induced cardiomyopathy, neoplasm, skin disorderNot yet recruitingPhase 1 / Phase 22026-01-29NCT07370506